Kodiak Sciences Inc.

KOD

Kodiak Sciences Inc.

KOD

Insider Sentiment (TTM):

Last Purchase:2025-12-18Last Sale:2026-06-04Shares Purchased (TTM):2,608,696Shares Sold (TTM):60,000

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:54,843,008Shares Outstanding:61,859,485Institutional Ownership Pct.:88.66%

Earnings Market Reaction:

Filing Date:2026-08-13Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	126	170	210	72	104	139	168	198	219	246	286	346
Prepaid Expense And Other Assets Current	5	6	5	4	4	4	4	5	5	6	4	5
Marketable Securities Current	-	-	-	-	-	-	-	-	-	-	0	0
Assets Current	131	175	215	76	108	143	172	202	225	252	289	351
Restricted Cash Noncurrent	6	6	6	6	6	6	6	6	6	6	6	6
Property Plant And Equipment Net	78	82	85	89	93	98	102	107	111	116	120	125
Operating Lease Right Of Use Asset	32	34	37	39	41	42	47	49	51	53	55	56
Other Assets Noncurrent	9	9	9	9	9	9	9	9	9	9	9	9
Assets	257	306	352	218	257	298	336	373	402	435	479	548
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	13	11	13	10	5	7	4	3	2	2	14	39
Accrued Liabilities Current	30	27	21	20	15	13	11	11	9	13	18	23
Operating Lease Liability Current	10	12	12	12	11	11	11	10	10	10	10	9
Liabilities Current	53	50	46	42	31	31	26	24	21	25	42	71
Operating Lease Liability Noncurrent	43	44	47	50	54	57	60	63	66	69	72	74
Liabilities	196	194	194	194	186	189	185	187	187	194	214	245
Other Liabilities Noncurrent	-	-	-	-	-	-	-	-	-	-	0	0
Stockholders Equity
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital Common Stock	1,744	1,729	1,716	1,526	1,511	1,495	1,479	1,470	1,455	1,437	1,418	1,395
Retained Earnings Accumulated Deficit	-1,683	-1,617	-1,559	-1,502	-1,441	-1,386	-1,329	-1,285	-1,241	-1,196	-1,153	-1,093
Stockholders Equity	61	112	157	24	70	109	150	185	215	241	266	302
Liabilities And Stockholders Equity	257	306	352	218	257	298	336	373	402	435	479	548
Accumulated Other Comprehensive Income Loss Net Of…	-	-	-	-	-	-	-	-	-	-	0	0
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Authorized	10	10	10	10	10	10	10	10	10	10	10	10
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	-	-	0	-	-	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	490	490	490	490	490	490	490	490	490	490	490	490
Common Stock Shares Issued	63	62	62	53	53	53	53	53	53	53	53	52
Shares Outstanding	63	62	62	53	53	53	53	53	53	53	53	52

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-15.96%	-17.72%	-5.20%	-	-	-	-	-	-	-	-	-
2025	7.11%	0.25%	68.78%	22.04%	74.71%	110.32%	28.99%	37.89%	20.67%	17.63%	-4.96%	-5.19%
2024	-22.73%	-37.17%	-28.34%	-9.41%	4.31%	50.59%	47.74%	72.08%	20.75%	-7.19%	14.38%	26.80%
2023	-	-	-	-29.90%	-42.52%	-21.59%	64.58%	56.77%	109.90%	-36.12%	-37.26%	-46.58%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	2.49	3.54	4.72	1.78	3.48	4.62	6.72	8.42	10.59	10.12	6.93	4.96
Quick Ratio	2.39	3.42	4.61	1.70	3.36	4.50	6.57	8.22	10.34	9.89	6.84	4.88
Working Capital	78.59M	125.69M	169.28M	33.30M	76.91M	111.81M	146.36M	178.43M	203.43M	226.66M	247.58M	280.15M
Leverage & Debt
Debt to Equity	3.20	1.73	1.23	8.20	2.65	1.74	1.23	1.01	0.87	0.80	0.80	0.81
Interest Coverage TTM	-	-	-	-	-	-	-	-	-42,382.40	-27,640.11	-21,332.38	-16,941.94
Debt Ratio	0.76	0.63	0.55	0.89	0.73	0.63	0.55	0.50	0.47	0.45	0.45	0.45
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Per Share Metrics
Diluted EPS TTM	-3.86	-3.73	-4.32	-4.11	-3.79	-3.61	-3.35	-3.64	-3.76	-4.43	-4.97	-5.17
Free Cash Flow Per Share TTM	-2.39	-2.40	-2.57	-1.86	-1.64	-2.04	-2.24	-2.80	-3.02	-3.35	-3.73	-3.70
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Growth Metrics
Net Income Growth (1Y)	21.10%	21.00%	30.51%	13.42%	1.09%	-18.10%	-32.36%	-29.40%	-33.77%	-24.65%	-21.97%	-23.87%
EPS Growth (1Y)	2.06%	3.18%	28.98%	12.90%	0.65%	-18.46%	-32.57%	-29.62%	-33.99%	-24.90%	-22.21%	-24.12%
Valuation Metrics
P/E TTM	-10.08	-10.22	-6.47	-3.98	-0.99	-0.78	-2.97	-0.72	-0.62	-1.19	-0.61	-0.35
P/B TTM	39.94	21.04	9.45	36.52	2.80	1.36	3.48	0.74	0.58	1.15	0.60	0.31
Market Cap	2.44B	2.36B	1.49B	865.31M	196.87M	148.22M	523.20M	137.33M	123.50M	276.21M	159.34M	94.42M
Enterprise Value	2.31B	2.19B	1.28B	793.27M	92.70M	9.37M	355.13M	-60.54M	-95.72M	30.29M	-126.17M	-251.25M
Calculated Values
Free Cash Flow TTM	-149.48M	-148.39M	-136.79M	-98.21M	-86.61M	-107.42M	-117.69M	-147.22M	-158.88M	-175.76M	-195.53M	-193.95M
Net Debt	-125.90M	-169.53M	-209.86M	-72.04M	-104.17M	-138.85M	-168.07M	-197.86M	-219.23M	-245.92M	-285.51M	-345.67M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-04Sale

Owner: Borgeson, John A.

Title: Chief Financial Officer

Shares: 30,000

Price/Share: $34.34

Value: $1,030,200.00

Shares Owned: 211,930

Relationship: Officer

Ownership: Direct

2026-04-02Sale

Owner: Borgeson, John A.

Title: Chief Financial Officer

Shares: 30,000

Price/Share: $40.52

Value: $1,215,600.00

Shares Owned: 183,316

Relationship: Officer

Ownership: Direct

2025-12-18Purchase

Owner: Baker, Brothers Life Scie…

Title: -

Shares: 2,608,696

Price/Share: $23.00

Value: $60,000,008.00

Shares Owned: 18,358,772

Relationship: Director,TenPercentOwner

Ownership: Indirect

2025-06-17Sale

Owner: Borgeson, John A.

Title: See Remarks

Shares: 723

Price/Share: $3.65

Value: $2,638.95

Shares Owned: 183,316

Relationship: Officer

Ownership: Direct

2024-06-17Sale

Owner: Borgeson, John A.

Title: See Remarks

Shares: 2,874

Price/Share: $2.75

Value: $7,903.50

Shares Owned: 182,164

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-04	Borgeson, John A.	Officer	Chief Financial Officer	Direct	Sale	30,000	34.34	$1,030,200.00	211,930	4
2026-04-02	Borgeson, John A.	Officer	Chief Financial Officer	Direct	Sale	30,000	40.52	$1,215,600.00	183,316	4
2025-12-18	Baker, Brothers Life Scie…	Director,TenPercentOwner	-	Indirect	Purchase	2,608,696	23.00	$60,000,008.00	18,358,772	4
2025-06-17	Borgeson, John A.	Officer	See Remarks	Direct	Sale	723	3.65	$2,638.95	183,316	4
2024-06-17	Borgeson, John A.	Officer	See Remarks	Direct	Sale	2,874	2.75	$7,903.50	182,164	4
2024-06-12	Borgeson, John A.	Officer	See Remarks	Direct	Sale	1,558	2.92	$4,549.36	179,544	4
2023-06-16	Borgeson, John A.	Officer	See Remarks	Direct	Sale	2,749	9.23	$25,373.27	178,077	4
2023-06-16	Ehrlich, Jason	Officer	See Remarks	Direct	Sale	2,258	9.23	$20,841.34	61,924	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

88.66%

Inst. Shares: 54,843,008

Shares Outstanding: 61,859,485

2025-12-31

103.69%

Inst. Shares: 55,171,200

Shares Outstanding: 53,208,311

2025-09-30

80.68%

Inst. Shares: 42,646,935

Shares Outstanding: 52,859,308

2025-06-30

74.56%

Inst. Shares: 39,351,515

Shares Outstanding: 52,779,162

2025-03-31

76.97%

Inst. Shares: 40,601,262

Shares Outstanding: 52,746,318

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	54,843,008	61,859,485	88.66%
2025-12-31	55,171,200	53,208,311	103.69%
2025-09-30	42,646,935	52,859,308	80.68%
2025-06-30	39,351,515	52,779,162	74.56%
2025-03-31	40,601,262	52,746,318	76.97%
2024-12-31	39,077,628	52,583,148	74.32%
2024-09-30	37,023,937	52,616,183	70.37%
2024-06-30	37,991,062	52,554,215	72.29%
2024-03-31	40,836,443	52,510,460	77.77%
2023-12-31	38,215,313	52,414,256	72.91%
2023-09-30	39,501,596	52,455,620	75.30%
2023-06-30	40,310,571	52,378,729	76.96%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Kodiak Sciences Inc. (KOD) — SEC Financial Statements & Analysis

Kodiak Sciences Inc. (KOD) is a biological products, (no diagnostic substances) company, incorporated in DE. Kodiak Sciences Inc. trades on Nasdaq as: KOD. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Kodiak Sciences Inc. reported a Debt-to-Equity ratio of 3.20x, a Price-to-Book (P/B) ratio of 39.94x (TTM), at a market cap of $2.44B. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity: 3.20x
P/B TTM: 39.94x
Market Cap: $2.44B

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Kodiak Sciences Inc. in?

Kodiak Sciences Inc. (KOD) operates in the Biological Products, (No Diagnostic Substances) industry.

What is KOD's market cap?

Kodiak Sciences Inc. (KOD) has a market capitalization of $2.44B as of 2026-06-30.

What exchange does KOD trade on?

Kodiak Sciences Inc. (KOD) trades on the Nasdaq.

Where is Kodiak Sciences Inc. incorporated?

Kodiak Sciences Inc. is incorporated in DE.